Tri-Tren 150 mg is an oil-based injectable blend of Trenbolone Acetate, Trenbolone Enanthate, and Trenbolone Hexahydrobenzylcarbonate manufactured by Dragon Pharma and dosed at 150 mg/mL in a 10 mL vial.
Tri-Tren 150 mg combines three esterified forms of the potent 19-nor anabolic steroid trenbolone in a single injectable formulation: trenbolone acetate (50 mg/mL), trenbolone enanthate (50 mg/mL), and trenbolone hexahydrobenzylcarbonate (50 mg/mL). Trenbolone is a synthetic anabolic-androgenic steroid belonging to the nandrolone group, characterized by strong anabolic properties and potent nutrient partitioning effects.
Each ester contributes distinct release characteristics to the blend, creating a multi-phase pharmacokinetic profile. Trenbolone acetate is the shortest ester, with a half-life of 1–2 days, providing rapid onset of action. Trenbolone hexahydrobenzylcarbonate (commonly known as Parabolan) has a half-life of approximately 8 days, offering intermediate release. Trenbolone enanthate has the longest duration of action among trenbolone esters, with a half-life of approximately 11 days. This tri-ester design is intended to deliver both rapid initial effects and sustained anabolic activity. Trenbolone is classified as an anabolic agent that stimulates the development of muscle mass, strength, and power.
Trenbolone is known to be up to five times more potent compared with testosterone on a milligram-for-milligram basis. It possesses very strong anabolic properties and is often used in non-medical bodybuilding contexts to enhance muscle recovery through increased protein synthesis and strength gains. However, trenbolone is not approved for human use in the United States and is associated with significant adverse effects, with research indicating that approximately 90% of users experience injurious side effects. Non-medical use of Tri-Tren 150 mg falls outside approved indications and may carry substantial health risks.
Tri-Tren 150 mg uses MCT oil as its carrier, providing an oil base for the three-ester trenbolone blend. The 150 mg/mL total concentration delivers 50 mg of each trenbolone ester per mL.
Tri-Tren 150 mg is a tri-ester blend combining three esterified forms of trenbolone with different release profiles. The combination is designed to provide both rapid onset and prolonged anabolic activity.
Trenbolone is a synthetic anabolic-androgenic steroid that belongs to the nandrolone group. It is a heavily modified 19-nortestosterone derivative characterized by its profound anabolic efficiency and resistance to both aromatization and 5α-reduction. The three esters in Tri-Tren 150 mg are formed by esterification at the 17-β position of the trenbolone molecule, which prolongs the duration of action after intramuscular administration.
The acetate ester is the shortest, with a half-life of 1–2 days, providing rapid elevation of blood trenbolone levels. The hexahydrobenzylcarbonate ester has a half-life of about 8 days, while the enanthate ester has the longest duration of action at approximately 11 days. This tri-ester design creates a stepped release profile that begins quickly and maintains elevated trenbolone levels for an extended period.
Trenbolone exhibits potent anabolic effects with minimal aromatization and a reduced profile of estrogenic side effects compared to testosterone. It is classified by the DEA as a Schedule III controlled substance.
The tri-ester design of Tri-Tren 150 mg produces a multi-phase release profile. The acetate component provides rapid onset within hours to days, while the hexahydrobenzylcarbonate and enanthate components extend activity over approximately 8 and 11 days respectively. In non-medical contexts, this blend is typically referenced as being administered every other day or twice weekly. The extended clearance means that side effects, if they occur, may persist for several weeks after discontinuation.
Dragon Pharma offers individual trenbolone preparations for users who prefer to control each ester separately. Trenbolone 100 provides trenbolone acetate at 100 mg/mL, Trenbolone 200 provides trenbolone enanthate at 200 mg/mL, and Parabolan provides trenbolone hexahydrobenzylcarbonate at 100 mg/mL. The tri-ester blend in Tri-Tren 150 mg combines all three in a fixed 1:1:1 ratio.
In non-medical bodybuilding contexts, trenbolone blends are commonly referenced for body recomposition purposes. A testosterone base is frequently referenced alongside trenbolone, as the compound suppresses endogenous testosterone production. Aromatase inhibitors are sometimes referenced when the testosterone component produces estrogenic effects.
Published laboratory reports for Tri-Tren 150 mg are shown below with the test date, measured concentration and percentage of the product's 150 mg/mL label claim.
View Report
View Report
View Report
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every vial or production batch.
The information below is provided for educational reference only. Trenbolone is not approved for human use; non-medical use falls outside any approved indications and carries substantial health risks.
In non-medical bodybuilding contexts, Tri-Tren 150 mg is commonly referenced in the range of 1 mL every other day, which equates to approximately 525 mg per week. Some users reference 75 mg pinned every 3rd day as a starting protocol. Because of the tri-ester design, injection frequency can vary from every other day to twice weekly. The 150 mg/mL concentration means that 1 mL provides 50 mg of each trenbolone ester.
| Use Case | Common Reference Range | Injection Frequency |
|---|---|---|
| Beginner (non-medical) | 0.5–1 mL | Every other day |
| Intermediate (non-medical) | 1 mL | Every other day |
| Advanced (non-medical) | 1.5–2 mL | Every other day or daily |
In non-medical bodybuilding contexts, Tri-Tren 150 mg is sometimes stacked with a testosterone base such as Cypionate 250 or Enantat 250. A testosterone base is commonly referenced when using trenbolone, as the compound suppresses endogenous testosterone production. Some users reference adding Sustanon 250 at 125 mg twice per week alongside tri-tren.
Cycle lengths of 8–12 weeks are commonly referenced for trenbolone blends in non-medical contexts. Because trenbolone is a 19-nor compound, it can produce deeper and more prolonged suppression of the hypothalamic-pituitary-gonadal axis compared to testosterone, and recovery may take longer.
Trenbolone is associated with a distinctive and significant side effect profile. Research indicates that approximately 90% of users experience injurious side effects. Common side effects include insomnia and night sweats, which are considered signature trenbolone effects. Elevated blood pressure, with increases of 10–25 mmHg systolic commonly reported, is also frequently referenced.
Other reported side effects include aggression and short temper, oily skin and acne, and dark-colored urine. Severe acne and gynaecomastia affect approximately one-third of all users, along with excessive body hair, stretch marks, hypertension and cardiac arrhythmia. Trenbolone has also been associated with significant lipid profile alterations and published case reports of severe liver injury. Prolactin elevation is a recognized concern with 19-nor compounds.
After completing a cycle with Tri-Tren 150 mg, post-cycle therapy is commonly recommended in non-medical contexts to help restore endogenous testosterone production. Because the blend contains long-acting esters, PCT should begin approximately 2–3 weeks after the final injection to allow the esters to clear. Agents such as Clomid or Nolvadex are frequently referenced for this purpose. Research indicates that HPG suppression from 19-nors is deeper and slower to reverse compared to testosterone-only cycles. Bloodwork and, where possible, medical guidance can help inform recovery strategy.
Dosing strategies, support compounds and recovery protocols should be adjusted based on experience level and bloodwork where possible. The information above is for educational reference and does not constitute medical advice.
Tri-Tren 150 mg contains three esterified forms of trenbolone. Trenbolone is not approved for human use and is classified as a Schedule III controlled substance in the United States. It is associated with significant cardiovascular, hepatic, and neurological risks.
Trenbolone is a synthetic analogue of testosterone belonging to the nandrolone group with strong anabolic and limited androgenic effects. It is used illegally by professional or amateur athletes who want to improve athletic performance and appearance. Non-medical use for bodybuilding or performance enhancement falls outside any approved indication and may carry significant health risks.
Trenbolone is classified by the DEA as a Schedule III controlled substance. It is also listed as a potential endocrine disrupting compound.
Use of Tri-Tren 150 mg for bodybuilding or performance enhancement falls outside approved medical indications. Research indicates that approximately 90% of users experience injurious side effects.
Trenbolone acts systemically on the body, and its side effects can manifest as symptoms from different systems. Severe acne and gynaecomastia affect approximately one-third of all users, as well as excessive body hair, stretch marks, hypertension and cardiac arrhythmia.
Common side effects referenced in non-medical contexts include insomnia and night sweats, elevated blood pressure (with increases of 10–25 mmHg systolic commonly reported), aggression and short temper, oily skin and acne, and dark-colored urine. Cardio intolerance, where zone-2 work becomes significantly harder within 2–3 weeks, is also frequently referenced.
Due to the lack of available knowledge on the subject, many of the effects of trenbolone use remain unknown. The fact that multiple anabolic steroids may be used simultaneously presents a significant problem in their study.
Trenbolone is not approved for human use and should not be considered appropriate for any medical condition. Individuals with pre-existing cardiovascular disease, hepatic or renal impairment, or hormone-sensitive conditions should exercise particular caution. Existing medical conditions should be discussed with a qualified healthcare professional before any consideration of use.
If Tri-Tren 150 mg is used in any context, monitoring of blood pressure, lipid profiles, and liver function is important given the known effects of trenbolone. Research recommends bail-out criteria including stopping the cycle if sustained blood pressure exceeds 150/95 despite medication, resting heart rate exceeds 90 at rest for more than a few days, or persistent insomnia unresponsive to normal sleep hygiene after week 3. Bloodwork before, during, and after a cycle is commonly referenced as a risk-reduction strategy in non-medical bodybuilding contexts.
Keep the vial securely stored and protected from conditions that could compromise the product or container. Store at controlled room temperature and protect from light and moisture. Inspect the vial and solution before use and do not use a product that appears damaged, contaminated or otherwise abnormal.
Keep all medications and injectable products out of the reach of children. Follow the storage instructions provided with the product packaging.
Tri-Tren 150 mg by Dragon Pharma is shipped in original manufacturer packaging with discreet, privacy-focused handling.
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details.
To verify your Tri-Tren 150 mg product, use the security code on the vial label and cross-check it on the Dragon Pharma official site. Original Dragon Pharma packaging and batch-linked lab proof help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Proper storage conditions help preserve formulation stability and overall product integrity throughout shelf life.
Store at controlled room temperature (15–25°C) and protect from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the oily formulation.
Keep the vial in its original packaging until use. Do not freeze. Before administration, inspect the solution and avoid use if it appears cloudy, discolored, contains particulate matter, or if the vial or seal is compromised.
Keep out of reach of children. Follow proper handling and sterile injection practices when administering the product.
Answers to common questions about Tri-Tren 150 mg, the trenbolone tri-ester blend, usage considerations, product strength and laboratory testing.
Tri-Tren 150 mg contains three esterified forms of trenbolone, a synthetic anabolic-androgenic steroid belonging to the nandrolone group. Trenbolone is not approved for human use. In non-medical bodybuilding settings, Tri-Tren 150 mg is commonly referenced for body recomposition purposes, though such use falls outside approved indications.
Because of the tri-ester design, Tri-Tren 150 mg can be administered every other day or twice weekly in non-medical contexts. Some users reference 75 mg pinned every 3rd day as a starting protocol. The 150 mg/mL concentration means that 1 mL provides 50 mg of each trenbolone ester.
In non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after a trenbolone cycle to help restore endogenous testosterone production. Research indicates that HPG suppression from 19-nors is deeper and slower to reverse compared to testosterone-only cycles. Because the blend contains long-acting esters, PCT should begin approximately 2-3 weeks after the final injection. Agents such as Clomid or Nolvadex are commonly referenced for this purpose.
The three esters in Tri-Tren 150 mg have different release profiles. Trenbolone acetate has a half-life of 1-2 days, providing rapid onset. Trenbolone hexahydrobenzylcarbonate has a half-life of approximately 8 days, and trenbolone enanthate has the longest duration of action at approximately 11 days. All three ultimately release the same active hormone, trenbolone.
Because of the acetate component, Tri-Tren 150 mg has a relatively rapid onset compared to single long-ester trenbolone preparations. In non-medical contexts, users commonly reference noticing effects within the first week to 10 days of use. The enanthate and hexahydrobenzylcarbonate components then provide sustained activity over the following weeks.
There is no single blend that is universally best. Tri-Tren 150 mg combines three trenbolone esters in a fixed ratio for both rapid and sustained release. The individual preparations Trenbolone 100 (acetate), Trenbolone 200 (enanthate), and Parabolan (hexahydrobenzylcarbonate) are also referenced, allowing users to adjust the ratio of esters independently.
Parabolan contains only trenbolone hexahydrobenzylcarbonate, a single long-acting ester. Tri-Tren 150 mg adds trenbolone acetate and trenbolone enanthate to the blend, providing both faster onset and additional release phases. Tri-Tren 150 mg is a tri-ester blend, while Parabolan is a single-ester product.
A milligram amount cannot be classified as appropriate or excessive without considering the specific context, individual response, and other factors. In non-medical bodybuilding contexts, Tri-Tren 150 mg is commonly referenced at 1 mL every other day, delivering approximately 525 mg per week. Research indicates that approximately 90% of users experience injurious side effects from trenbolone.
Tri-Tren 150 mg is labeled at 150 mg of total active compounds per mL, comprising 50 mg trenbolone acetate, 50 mg trenbolone enanthate, and 50 mg trenbolone hexahydrobenzylcarbonate per mL. It is supplied in a 10 mL vial, giving 1,500 mg of total labeled content per vial.
Yes. A published laboratory report dated March 25, 2026 measured Tri-Tren 150 mg at 150.07 mg, equivalent to 100.05% of its 150 mg/mL label claim.
The complete report can be viewed in the Lab Reports tab. Laboratory results apply to the tested sample represented by the individual report and should not be interpreted as a measurement of every vial.
Tri-Tren 150 mg contains trenbolone, a potent anabolic steroid that is not approved for human use. Research indicates that approximately 90% of users experience injurious side effects. Severe acne and gynaecomastia affect approximately one-third of all users, along with excessive body hair, stretch marks, hypertension and cardiac arrhythmia. Trenbolone is also associated with significant lipid profile alterations and published case reports of severe liver injury. The combination of three esters in a single injectable introduces compounded cardiovascular and androgenic stress that has not been evaluated in controlled clinical trials.
Yes. Trenbolone and its esters are prohibited substances in sport and can be detected in urine. The enanthate and hexahydrobenzylcarbonate esters have relatively long detection times due to their prolonged release profiles, with half-lives of approximately 8 and 11 days respectively. Athletes subject to drug testing should be aware that positive tests can result in sanctions.